RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS

被引:131
|
作者
Xiao, Shangxi [1 ]
Sanelli, Teresa [1 ]
Dib, Samar [1 ]
Sheps, David [1 ]
Findlater, Joseph [1 ]
Bilbao, Juan [2 ,3 ]
Keith, Julia [2 ,3 ]
Zinman, Lorne [3 ]
Rogaeva, Ekaterina [1 ]
Robertson, Janice [1 ,2 ]
机构
[1] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 3H2, Canada
[3] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON M5S 3H2, Canada
关键词
Tar DNA binding protein-43; TDP-43; Amyotrophic lateral sclerosis; UV-CLIP; RNA; Alternative splicing; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; FIBROBLAST GROWTH-FACTOR; NUCLEAR FACTOR TDP-43; BINDING PROTEIN; EXPRESSION; GENE; COMPLEX; CELLS; MOTOR;
D O I
10.1016/j.mcn.2011.02.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
TDP-43 is a predominantly nuclear DNA/RNA binding protein involved in transcriptional regulation and RNA processing. TDP-43 is also a component of the cytoplasmic inclusion bodies characteristic of amyotrophic lateral sclerosis (ALS) and of frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U). We have investigated the premise that abnormalities of TDP-43 in disease would be reflected by changes in processing of its target RNAs. To this end, we have firstly identified RNA targets of TDP-43 using UV-Cross-Linking and Immunoprecipitation (UV-CLIP) of SHSY5Y cells, a human neuroblastoma cell line. We used conventional cloning strategies to identify, after quality control steps, 127 targets. Results show that TDP-43 binds mainly to introns at UG/TG repeat motifs (49%) and polypyrimidine rich sequences (17.65%). To determine if the identified RNA targets of TDP-43 were abnormally processed in ALS versus control lumbar spinal cord RNA, we performed RT-PCR using primers designed according to the location of TDP-43 binding within the gene, and prior evidence of alternative splicing of exons adjacent to this site. Of eight genes meeting these criteria, five were differentially spliced in ALS versus control. This supports the premise that abnormalities of TDP-43 in ALS are reflected in changes of RNA processing. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:167 / 180
页数:14
相关论文
共 50 条
  • [1] TDP-43 in FTD and ALS
    Neumann, M.
    BRAIN PATHOLOGY, 2010, 20 : 7 - 7
  • [2] Characterizing TDP-43 interaction with its RNA targets
    Bhardwaj, Amit
    Myers, Michael P.
    Buratti, Emanuele
    Baralle, Francisco E.
    NUCLEIC ACIDS RESEARCH, 2013, 41 (09) : 5062 - 5074
  • [3] Developing RNA therapeutics for TDP-43 proteinopathy in ALS/FTD
    Copley, Katie
    Smirnov, Ashleigh
    Mayne, Leland
    Wang, Yuanhang
    Black, Ben E.
    Shorter, James
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 485A - 486A
  • [4] Developing RNA Therapeutics for TDP-43 Proteinopathy in ALS/FTD
    Copley, Katie E.
    Smirnov, Ashleigh
    Shorter, James
    FASEB JOURNAL, 2022, 36
  • [5] Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
    Hayes, Lindsey R.
    Kalab, Petr
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1061 - 1084
  • [6] TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
    Emma L. Scotter
    Han-Jou Chen
    Christopher E. Shaw
    Neurotherapeutics, 2015, 12 : 352 - 363
  • [7] TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
    Scotter, Emma L.
    Chen, Han-Jou
    Shaw, Christopher E.
    NEUROTHERAPEUTICS, 2015, 12 (02) : 352 - 363
  • [8] Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
    Lindsey R. Hayes
    Petr Kalab
    Neurotherapeutics, 2022, 19 : 1061 - 1084
  • [9] CK1δ/ε kinases regulate TDP-43 phosphorylation and are therapeutic targets for ALS-related TDP-43 hyperphosphorylation
    Ko, Vivian I.
    Ong, Kailee
    Cleveland, Don W.
    Yu, Haiyang
    Ravits, John M.
    NEUROBIOLOGY OF DISEASE, 2024, 196
  • [10] TDP-43 and Cytoskeletal Proteins in ALS
    Moritz Oberstadt
    Joseph Claßen
    Thomas Arendt
    Max Holzer
    Molecular Neurobiology, 2018, 55 : 3143 - 3151